Re:Doctor tells patient he doesn't have long to live through...
by Pharmakon on Friday March 08, 2019 @10:32PM
(#19344271)
This is the same AbbVie who’s treatment costs $26,000 right? I think it’s fair to say that’s priced well out of reach for most people, whatever the cost relative to Gilead’s product, which the CEO apologized for. The same AbbVie that sued the NHS? https://outline.com/brsHyA Incidentally Gilead made $5.8 billion in a single quarter so I think we can safely assume they managed to defray the cost of acquiring Pharmasset, don’t you think?
Companies making tens of billions a year while poor people suffer and die does seem to be a fairly negative situation, however you care to label it.
Companies making tens of billions a year while poor people suffer and die does seem to be a fairly negative situation, however you care to label it.